NCT03245723

Brief Summary

The purpose of this research is to determine the effect of premature birth on later heart function and metabolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 10, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

September 20, 2017

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2020

Completed
11 months until next milestone

Results Posted

Study results publicly available

February 4, 2021

Completed
Last Updated

February 4, 2021

Status Verified

January 1, 2021

Enrollment Period

2.4 years

First QC Date

August 8, 2017

Results QC Date

January 14, 2021

Last Update Submit

February 2, 2021

Conditions

Keywords

premature adultsprematurepremature lung functionpremature cardiac functionMRIPET

Outcome Measures

Primary Outcomes (2)

  • Cardiac Glucose Uptake During Normoxic Rest (µg/Min)

    Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

    Visit 1 (1 day)

  • Change in Glucose Uptake From Normoxia to Hypoxia (µg/Min)

    Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

    Visit 1 (1 day)

Study Arms (2)

Preterm

ACTIVE COMPARATOR

Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.

Procedure: Pulmonary Function TestingProcedure: ElectrocardiogramProcedure: Positron Emission TomographyProcedure: Magnetic Resonance Imaging

Term - Healthy Controls

PLACEBO COMPARATOR

Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.

Procedure: Pulmonary Function TestingProcedure: ElectrocardiogramProcedure: Positron Emission TomographyProcedure: Magnetic Resonance Imaging

Interventions

Subjects will undergo Spirometry and Plethysmography

PretermTerm - Healthy Controls

Subjects will undergo an electrocardiogram to ensure sinus rhythm

PretermTerm - Healthy Controls

Subjects will undergo positron emission tomography to detect images of the heart

PretermTerm - Healthy Controls

Subjects will undergo positron magnetic resonance imaging to detect images of the heart

PretermTerm - Healthy Controls

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • National Lung Project Cohort only- birth weight \<1500g and a gestational age \<36 weeks
  • Adults born preterm (Non-National Lung Project) only- gestational age ≤32 weeks OR birth weight ≤ 3lbs 5oz
  • Healthy Controls only- No personal history of known cardiovascular or pulmonary disease

You may not qualify if:

  • Metabolic Disorders that would affect Fludeoxyglucose uptake
  • Contraindications to positron emission tomography and/or magnetic resonance imaging
  • Pregnancy, if a female of child-bearing potential
  • A personal history of Type I or Type II diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UW Madison

Madison, Wisconsin, 53792, United States

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Respiratory Physiological PhenomenaMagnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Circulatory and Respiratory Physiological PhenomenaSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Results Point of Contact

Title
Dr. Kara Goss
Organization
UT Southwestern Medical Center, Dallas, Texas

Study Officials

  • Kara N Goss, MD

    The University of Wisconsin School of Medicine and Public Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Young adults born premature (some of them are registered on the National Lung Project) and Healthy Controls will undergo pulmonary function testing, cardiac positron emission tomography, and cardiac magnetic resonance imaging.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2017

First Posted

August 10, 2017

Study Start

September 20, 2017

Primary Completion

February 26, 2020

Study Completion

February 26, 2020

Last Updated

February 4, 2021

Results First Posted

February 4, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations